Skip to main content
. 2011 Jul 26;6(7):e22155. doi: 10.1371/journal.pone.0022155

Figure 3. Activity of DB766 (ip.) combined or not with benznidazole (Bz) upon T. cruzi-infection in mice.

Figure 3

(A): Parasitemia curve, (B) Cumulative Mortality and (D) Ponderal Curve of infected mice treated or not for twenty daily doses with 50 mg/kg/day DB766 combined or not with 50 mg/kg/day Bz. Plasma levels of (D) Glutamate pyruvate transaminase (GPT) and of (E) Creatinine kinase (CK) at 14 dpi from uninfected, untreated, DB766, Bz and combined therapy treated mice.